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Induced Pluripotent Stem Cell Cardiomyocytes Provide an In Vitro Model of Heart
Disease and a Potential Source of Cell Replacement
Ischemic heart disease remains a major cause of death and disability worldwide (Moran
Andrew E. et al., 2014). While interventions for heart disease have come a long way, restoring
functionality to damaged myocardium remains a challenge. Both mechanical and electrical repair
of the host myocardium are essential to salvage the damaged tissue. This is especially difficult
following a myocardial infarction (MI) as the infarct area is subject to quick and extensive cell
death via necrosis then apoptosis (Prabhu & Frangogiannis, 2016). Stem cells have emerged as a
candidate for potential replacement therapies. Adult stem cells (ASCs) are taken from bone
marrow or adipose tissue. Induced Pluripotent Stem Cells (iPSCs) are cells that have been
reverse engineered into a pluripotent state. Both ASCs and iPSCs have proven preclinical
usefulness in treating heart disease (Gao et al., 2007; Guo et al., 2020). It is theorized that ASCs
act primarily through paracrine signaling while iPSCs may have a greater capacity to
differentiate into cardiac myocytes (CMs) in vivo (Guo et al., 2020). Additionally, iPSCs can
differentiate into CMs (iPSC-CMs) in vitro, making them a useful cellular model for heart
disease (Karakikes et al., 2015; Smith et al., 2017). This profile will highlight the uses of iPSCs
as they pertain to modeling and treating MI. Attention will be paid to stem coupling,
electrophysiology, and experimental designs that investigate the role of gap junctions in stem cell
therapies.
Background
Myocardial Infarction
MI occurs when a coronary artery becomes occluded and leads to tissue stress and
possibly death. MI is especially deadly in humans as there is little redundancy in cardiac arterial

3
networks. The region of myocardium supplied by the affected coronary artery becomes ischemic,
loosing essential access to oxygen and nutrients. The CMs immediately affected become
necrotized and irreversibly damaged. In response to this stress, the surrounding cardiac myocytes
release pro-apoptotic factors leading to massive but possibly preventable cell death and
dysfunction. Calcium ions (Ca2+) are a potential apoptotic factor mediating this preventable cell
death. Under normal conditions, Ca2+ ions aid in the synchronization of cardiac action potentials.
However, excess intracellular accumulation of Ca2+ ions has been shown to trigger both
mechanical and electrical dysfunction of CMs. These Ca2+ ions travel primarily through
Connexin-43 (Cx43) based gap junctions (Sridhar et al., 2020). This implicates Cx43 as a
potential therapeutic target in the prevention of deadly post MI pathologies such as heart failure
and arrythmias.
Stem Cell Therapy
Stem cell therapies attempt to fully replace dead or dysfunctional tissue. Originally
therapies sought to generate functionally identical patches of replacement tissue from exogenous
cell sources. However new paradigms, specifically in cardiology, emphasize the role of paracrine
factors in aiding the natural remodeling process of the affect heart. Bone marrow derived
mesenchymal stem cells (MSCs) have been shown to aid in the repair of damaged myocardium
through the release of protective paracrine factors such as insulin-like growth factor-1 (IGF-1)
and VEGF (Lin et al., 2020; Zisa et al., 2009). Additionally MSCs have been shown to express
Cx43 and potentially protect against arrythmias (Mureli et al., 2013). This suggests early cell
communication between MSCs and CMs is essential to developing an effective therapy. CMs
like many primary cell lines, have an incredibly limited lifespan in culture. This makes in vitro
research especially difficult. iPSCs were originally developed as potential source of cells for
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direct replacement. However, they have also proven to successfully model CMs in vitro (Smith
et al., 2017).
Modeling MI and Therapies with Stem Cells
In Vitro Physiology
iPSCs were originally developed as an alternative to embryonic stem cells. The first
iPSCs were made by reprogramming skin fibroblasts using transcription factors (Glicksman,
2018). They are pluripotent, able to differentiate into any cell in the human body but not
totipotent, embryonic in origin. iPSC-CMs are created when a stromal cell is reprogrammed to a
pluripotent state and then driven down the developmental pathway of CMs. This is accomplished
via selective induction of gene expression. One method to drive a reprogrammed fibroblast down
a CM pathway is to subject it to growth factors such as activin-A and bone morphogenetic
protein 4 (BMP-4). This mimics the effects of the Activin/Nodal and BMP4 signaling pathways
that embryonic cells would experience when differentiating into mesodermal tissues such as
myocardium (Kattman et al., 2011). Other pathways that have been exploited to create iPSCCMs include the transforming growth factor-β (TGF-β) and Wnt pathways (Karakikes et al.,
2015). When fully differentiated iPSC-CMs demonstrate high homology with CMs, expressing
genes (MYL2, MYL7, MYH6, and TNNT2) and all functional ion channels (sodium, potassium,
and calcium) associated with terminal cardiac differentiation (Karakikes et al., 2015). In
addition, fully differentiated iPSC-CMs display transverse tubules, sarcomeres, and similar
mitochondrial densities characteristic of adult CMs. These findings are functionally supported by
iPSC-CMs ability to spontaneously contract in vitro (Ronaldson-Bouchard et al., 2018).
Gap Junctions
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Of particular interest in models of MI are gap junction channels. Gap junctions are
responsible for synchronous contraction via rapid ion transfer in the myocardium. Gap junctions
are composed of various proteins known as Connexins (Cx). Connexin 43 (Cx43) is the
dominate protein in ventricular CMs, and is implicated in both proper and pathological
functioning of the ventricles (Schulz et al., 2015). For this reason, Cx43 dysregulation, is likely
implicated in decreased cardiac out following heart failure and arrythmia following MI. iPSCCMs have been shown to express Cx43 and form Cx43 gap junctions with other cells, further
validating their use as a model for MI (Biendarra-Tiegs et al., 2020). MSCs have also been
shown to express Cx43 (Mureli et al., 2013). Taken together these findings suggest that cocultures of iPSC-CMs and MSCs can form cardiac gap junctions. This could be used as a model
to investigate early stem cell coupling and electrophysiological integration.
Figure 1
Human MSCs Express Cx43

Note. (A) Cx43 expression (green) in the hBM-MSC, (B) Negative controls. DAPI nuclear stain
is represented in blue for both A and B (Tietema & Geenen, 2019).
Figure 2
Human iPSCs Express Cx43
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Note. Cx43 expression (red) in iPSCs derived from embryonic fibroblasts. Nuclei are shown with
blue DAPI staining (Ke et al., 2013).
Figure 3
Human CMs express Cx43

Note. Human left ventricular CMs expressing Cx43 (red) gap junctions localized along an
intercalated disc. P2X1 receptors stained green (Jiang et al., 2005).
Genetic Manipulation
Genetic manipulation is a powerful tool to study gain or loss of function in cell models of
diseases. iPSC-CM alone are capable of directly modeling arrythmia, particularly genetically
acquired ion channel deficiencies (Smith et al., 2017). iPSC-CM have been shown to be sensitive
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to genetic manipulation through lentiviral transfection leading to overexpression of a desired
gene (Gorabi et al., 2019). In the case of MSCs, similar lentiviral techniques have proven
effective in upregulating transcription of target genes (Fan et al., 2019). It is theoretically
possible to upregulate Cx43 through similar manners in order to further study the role of gap
junctions in stem cell therapies for MI. Other methods of upregulating Cx43 in non-CMs have
been reported, including exposure to eicosapentaenoic acids, coleusin factor, and vascular
endothelial growth factor (VEGF) (Geng et al., 2007; Li et al., 2017; Yang et al., 2019). Further
investigation of these factors could lead to the development of a chemical cocktail that promotes
increased engraftment and electrical integration between MSCs and MI modeling iPSC-CMs.
VEGF in particular, is an appealing target in the treatment of MI as it is has been shown to
increase vascularity, improved left ventricular ejection fraction, and aid in stem cell retention in
pre-clinical treatments of MI (Matsumoto Ryo et al., 2005; Pons et al., 2008).
Experiments of Interest
Figure 4
Intercellular Traffic Through Cx43 Gap Junctions
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Note. Gap junctions, allow specific classes of molecules to transfer between cells. This enables
impermeable dyes to label cells and permeable dyes to mimic Ca2+transfer.
Coupling of iPSC-CMs and MSCs
One potential way to investigate the properties of stem cells is through co-culture
experiments. Co-cultures can be accomplished by combining two cell cultures from the same cell
line (i.e. MSCs and MSCs) or two cell cultures from different lines (i.e. iPSC-CMs and MSCs).
The iPSC-CMs, MSC co-culture model is especially interesting because it would allow
researchers to investigate early cell coupling following the introduction of MSCs into a
myocardial environment. Transfer of potentially pro-apoptotic factors such as Ca2+ ions through
Cx43 gap junctions could be measured using dye-transfer experiments. In a dye-transfer
experiment, the cell culture modeling the host, in this case the iPSC-CM, is represented in at a
greater density and marked with a transferable dye. The culture modeling transplanted cells, in
this case the MSCs, would be identified with an untransferable marker and represented at a lesser
density. This untransferable marker could either be a membrane impermeable dye or a
fluorescent cell surface tag. The cells cultures would then be introduced to one another and dye
transfer into the transplanted cells would be measured over time. Other outcomes of interest
include impact on spontaneous contractions, transplanted cell retention, and potential transfer of
membranes or other structures between cells.
Figure 5
Cell Coupling Experimental Diagram
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Electrical Conduction Through Co-cultures
Electrical conduction in transplanted stem cell models is of particular interest due to their
potential to correct or create arrythmias. Conduction through cultured myocytes can be measured
through optical mapping of fluorescent voltage sensitive dyes. This technique has been able to
measure transmembrane action potentials in neonatal rat ventricular myocytes. This is especially
relevant as it demonstrated upregulation of Cx43 gap junctions was directly implicated in an
increase in conduction velocity (Darrow Bruce J. et al., 1996). In theory this could be used to
measure action potential length and conduction velocity in an iPSC-CM culture before and after
co-culture with MSCs. Other experimental conditions of interest include co-culture of MSCs
exposed to either gap junction inhibitors, such as oleamide, or a gap junction promoter, such as
VEGF. These experiments would provide valuable insight into how and when stem cells
electrically integrate into the heart and affect arrythmias. Proper electrical integration is essential
for functional cell replacement, therefore having the ability to slow down or speed up the
ultimate conduction velocity through transplanted stem cells is necessary to maximize
therapeutic benefit. There are also gaps in our understanding of the relationship between VEGF
and Cx43 gap junctions. While there is strong evidence that VEGF increases the expression of
Cx43, theoretically an abundance of Cx43 gap junctions may decrease VEGF through negative
feedback. Little information on this topic exists, especially in the context of stem cells, justifying
the need for these types of experiments.
Figure 6
Electrical Conductance Experimental Diagram
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Conclusion
iPSC-CMs have clear usefulness in the in vitro study of MI. They reliably replicate the
physiology of adult CMs. Their controlled differentiations make them a well-characterized
model for studying genetic manipulation. The presence of functional Cx43 gap junctions in their
membrane makes them uniquely qualified to investigate the electrophysiological properties of
potential CM replacement candidates, including MSCs. Investigation of iPSC-CMs and MSCs
through the proposed experiments could offer a greater understanding of the cellular
environment transplanted stem cells experience leading to the optimization of MSC therapies.
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